Manufacturers Life Insurance Company, The Altimmune, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Altimmune, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 26,328 shares of ALT stock, worth $200,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,328
Previous 26,973
2.39%
Holding current value
$200,356
Previous $179,000
10.06%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALT
# of Institutions
185Shares Held
39.2MCall Options Held
913KPut Options Held
743K-
Black Rock Inc. New York, NY5.32MShares$40.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.98MShares$37.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.88MShares$29.5 Million0.01% of portfolio
-
State Street Corp Boston, MA3.41MShares$26 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$20.9 Million1.44% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $373M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...